MYBPC3 Gene Cardiomyopathy Dilated Genetic Test
At DNA Labs UAE, we offer the MYBPC3 Gene Cardiomyopathy Dilated Genetic Test for individuals who suspect they may have this genetic disorder affecting the heart muscle. This test helps in the diagnosis and management of familial dilated cardiomyopathy (DCM).
Test Details
The MYBPC3 gene cardiomyopathy, also known as familial dilated cardiomyopathy (DCM), is a genetic disorder that affects the heart muscle. It is caused by mutations in the MYBPC3 gene, which provides instructions for making a protein called cardiac myosin-binding protein C. This protein plays a crucial role in regulating the contraction and relaxation of heart muscle cells. Mutations in the MYBPC3 gene disrupt the normal functioning of this protein, leading to the development of cardiomyopathy.
Our MYBPC3 Gene Cardiomyopathy Dilated Genetic Test utilizes NGS (Next-Generation Sequencing) technology, which allows us to analyze multiple genes simultaneously. This advanced sequencing technology enables us to identify specific mutations in the MYBPC3 gene, helping to diagnose individuals with this condition.
Test Components and Price
The MYBPC3 Gene Cardiomyopathy Dilated Genetic Test costs AED 4400.0. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.
Report Delivery and Test Department
Once the sample is received, the report will be delivered within 3 to 4 weeks. The test is conducted in our Genetics department, where our team of experts specializes in cardiovascular and pneumology disorders.
Pre-Test Information
Before undergoing the MYBPC3 Gene Cardiomyopathy Dilated Genetic Test, it is essential to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by MYBPC3 Gene Cardiomyopathy Dilated NGS Genetic DNA Test.
Role of Genetic Testing
NGS genetic testing for MYBPC3 gene cardiomyopathy can be used for various purposes:
- Confirm a clinical diagnosis
- Identify carriers of the gene mutation
- Provide information for genetic counseling
- Guide treatment decisions
- Inform family members about their risk of developing the condition
It is important to note that genetic testing should always be done in consultation with a healthcare professional who specializes in genetics or cardiology. They can help interpret the results and provide appropriate recommendations for managing and treating MYBPC3 gene cardiomyopathy.
Don’t delay in getting tested. Contact DNA Labs UAE today to schedule your MYBPC3 Gene Cardiomyopathy Dilated Genetic Test.
Test Name | MYBPC3 Gene Cardiomyopathy dilated Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cardiovascular Pneumology Disorders |
Doctor | Cardiologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MYBPC3 Gene Cardiomyopathy, dilated NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYBPC3 Gene Cardiomyopathy, dilated NGS Genetic DNA Test gene MYBPC3 |
Test Details |
MYBPC3 gene cardiomyopathy, also known as familial dilated cardiomyopathy (DCM), is a genetic disorder that affects the heart muscle. It is caused by mutations in the MYBPC3 gene, which provides instructions for making a protein called cardiac myosin-binding protein C. Cardiac myosin-binding protein C plays a crucial role in regulating the contraction and relaxation of heart muscle cells. Mutations in the MYBPC3 gene disrupt the normal functioning of this protein, leading to the development of cardiomyopathy. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of MYBPC3 gene cardiomyopathy, NGS genetic testing can identify specific mutations in the MYBPC3 gene, helping to diagnose individuals with this condition. NGS genetic testing for MYBPC3 gene cardiomyopathy can be used to confirm a clinical diagnosis, identify carriers of the gene mutation, and provide information for genetic counseling. It can also help guide treatment decisions and inform family members about their risk of developing the condition. It is important to note that genetic testing should be done in consultation with a healthcare professional who specializes in genetics or cardiology. They can help interpret the results and provide appropriate recommendations for managing and treating MYBPC3 gene cardiomyopathy. |